BFGF binding cardiac extracellular matrix promotes the repair potential of bone marrow mesenchymal stem cells in a rabbit model for acute myocardial infarction

Biomedical Materials (Bristol)

Volumn 10, Issue 6, 2015, Pages

  Zhang, Guang Wei ^a   Gu, Tian Xiang ^a   Guan, Xiao Yu ^a   Sun, Xue Jun ^a,b   Qi, Xun ^a   Li, Xue Yuan ^a   Wang, Xiao Bing ^a   Yu, Lei ^a   Jiang, Da Qing ^a   Tang, Rui ^a   Li Ling, Jesse ^c  

^a CHINA MEDICAL UNIVERSITY   (China)

^b DALIAN MEDICAL UNIVERSITY   (China)

^c SICHUAN UNIVERSITY   (China)

Author keywords

coronary artery disease; extracellular matrix; fibroblast growth factor 2; stem cell transplantation; Ventricular remodeling

Indexed keywords

BINS; BIOMATERIALS; BONE; CARDIOLOGY; CELL CULTURE; CELL DEATH; DISEASES; FIBROBLASTS; SODIUM DODECYL SULFATE; SODIUM SULFATE;

CORONARY ARTERY DISEASE; EXTRACELLULAR MATRICES; FIBROBLAST GROWTH FACTOR 2; STEM CELL TRANSPLANTATION; VENTRICULAR REMODELING;

STEM CELLS;

BASIC FIBROBLAST GROWTH FACTOR RECEPTOR; DRUG IMPLANT; FIBROBLAST GROWTH FACTOR 2; PROTEIN BINDING;

ACUTE HEART INFARCTION; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BONE MARROW DERIVED MESENCHYMAL STEM CELL; CELL DIFFERENTIATION; CELL MIGRATION; CELL PROLIFERATION; CELL TRANSPLANTATION; CONTROLLED STUDY; EX VIVO STUDY; EXTRACELLULAR MATRIX; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE CELL; IN VITRO STUDY; NONHUMAN; QUANTITATIVE ANALYSIS; RABBIT; TISSUE REGENERATION; ABSORPTION; ACUTE DISEASE; ADMINISTRATION AND DOSAGE; ANIMAL; BONE MARROW TRANSPLANTATION; CHEMISTRY; DEVICES; DRUG IMPLANT; MESENCHYMAL STEM CELL TRANSPLANTATION; MYOCARDIAL INFARCTION; PATHOLOGY; SYNTHESIS; TISSUE SCAFFOLD; TRANSPLANTATION; TREATMENT OUTCOME;

ABSORPTION, PHYSICOCHEMICAL; ACUTE DISEASE; ANIMALS; BONE MARROW TRANSPLANTATION; DRUG IMPLANTS; EXTRACELLULAR MATRIX; FIBROBLAST GROWTH FACTOR 2; MESENCHYMAL STEM CELL TRANSPLANTATION; MYOCARDIAL INFARCTION; PROTEIN BINDING; RABBITS; TISSUE SCAFFOLDS; TREATMENT OUTCOME;

EID: 84950123271     PISSN: 17486041     EISSN: 1748605X     Source Type: Journal    
DOI: 10.1088/1748-6041/10/6/065018     Document Type: Article

References (35)

1. Allman A J, McPherson T B, Merrill L C, Badylak S F and Metzger D W 2002 The Th2-restricted immune response to xenogeneic small intestinal submucosa does not influence systemic protective immunity to viral and bacterial pathogens Tissue Eng. 8 53-62
2. Assmus B et al 2006 Transcoronary transplantation of progenitor cells after myocardial infarction New Engl. J. Med. 355 1222-32
3. Badylak S F, Freytes D O and Gilbert T W 2009 Extracellular matrix as a biological scaffold material: structure and function Acta Biomater. 5 1-13
4. Baiguera S, Del Gaudio C, Lucatelli E, Kuevda E, Boieri M, Mazzanti B, Bianco A and Macchiarini P 2014 Electrospun gelatin scaffolds incorporating rat decellularized brain extracellular matrix for neural tissue engineering Biomaterials 35 1205-14
5. Bianchi G, Banfi A, Mastrogiacomo M, Notaro R, Luzzatto L, Cancedda R and Quarto R 2003 Ex vivo enrichment of mesenchymal cell progenitors by fibroblast growth factor 2 Exp. Cell Res. 287 98-105
6. Cheung H K, Han T T, Marecak D M, Watkins J F, Amsden B G and Flynn L E 2014 Composite hydrogel scaffolds incorporating decellularized adipose tissue for soft tissue engineering with adipose-derived stem cells Biomaterials 35 1914-23
7. Choi S C, Kim S J, Choi J H, Park C Y, Shim W J and Lim D S 2008 Fibroblast growth factor - 2 and -4 promote the proliferation of bone marrow mesenchymal stem cells by the activation of the PI3K-Akt and ERK1/2 signaling pathways Stem Cells Dev. 17 725-36
8. Christman K L and Lee R J 2006 Biomaterials for the treatment of myocardial infarction J. Am. Coll. Cardiol. 48 907-13
9. Connelly J T, Garcia A J and Levenston M E 2008 Interactions between integrin ligand density and cytoskeletal integrity regulate BMSC chondrogenesis J. Cell. Physiol. 217 145-54
10. Debiais F, Lefevre G, Lemonnier J, Le Mee S, Lasmoles F, Mascarelli F and Marie P J 2004 Fibroblast growth factor-2 induces osteoblast survival through a phosphatidylinositol 3-kinase-dependent, -beta-catenin-independent signaling pathway Exp. Cell Res. 297 235-46
11. Fishman J M et al 2013 Immunomodulatory effect of a decellularized skeletal muscle scaffold in a discordant xenotransplantation model Proc. Natl Acad. Sci. USA 110 14360-5
12. Godier-Furnemont A F, Martens T P, Koeckert M S, Wan L, Parks J, Arai K, Zhang G, Hudson B, Homma S and Vunjak-Novakovic G 2011 Composite scaffold provides a cell delivery platform for cardiovascular repair Proc. Natl Acad. Sci. USA 108 7974-9
13. Jawad H, Ali N N, Lyon A R, Chen Q Z, Harding S E and Boccaccini A R 2007 Myocardial tissue engineering: a review J. Tissue Eng. Regen. Med. 1 327-42
14. Laham R J, Post M, Rezaee M, Donnell-Fink L, Wykrzykowska J J, Lee S U, Baim D S and Sellke F W 2005 Transendocardial and transepicardial intramyocardial fibroblast growth factor-2 administration: myocardial and tissue distribution. Drug Metab. Dispos. 33 1101-7
15. Langer H F et al 2009 Platelet derived bFGF mediates vascular integrative mechanisms of mesenchymal stem cells in vitro. J. Mol. Cell. Cardiol. 47 315-25
16. Liao D, Wang X, Lin P H, Yao Q and Chen C J 2009 Covalent linkage of heparin provides a stable anti-coagulation surface of decellularized porcine arteries J. Cell. Mol. Med. 13 2736-43
17. Lu G, Haider H K, Jiang S and Ashraf M 2009 Sca-1 + stem cell survival and engraftment in the infarcted heart: dual role for preconditioning-induced connexin-43 Circulation 119 2587-96
18. Lunde K et al 2006 Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction New Eng. J. Med. 355 1199-209
19. Lutolf M P and Hubbell J A 2005 Synthetic biomaterials as instructive extracellular microenvironments for morphogenesis in tissue engineering Nat. Biotechnol. 23 47-55
20. Meyer G P et al 2006 Intracoronary bone marrow cell transfer after myocardial infarction: eighteen months' follow-up data from the randomized, controlled BOOST (BOne marrOw transfer to enhance ST-elevation infarct regeneration) trial Circulation 113 1287-94
21. Miyahara Y et al 2006 Monolayered mesenchymal stem cells repair scarred myocardium after myocardial infarction Nat. Med. 12 459-65
22. Pati F, Jang J, Ha D H, Won Kim S, Rhie J W, Shim J H, Kim D H and Cho D W 2014 Printing 3D tissue analogues with decellularized extracellular matrix bioink Nat. Commun. 5 3935
23. Robertson M J, Dries-Devlin J L, Kren S M, Burchfield J S and Taylor D A 2014 Optimizing recellularization of whole decellularized heart extracellular matrix PLoS One 9 e90406
24. Schachinger V et al 2006 Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction New England J. Med. 355 1210-21
25. Seif-Naraghi S B, Horn D, Schup-Magoffin P J and Christman K L 2012 Injectable extracellular matrix derived hydrogel provides a platform for enhanced retention and delivery of a heparin-binding growth factor Acta Biomater. 8 3695-703
26. Sinanan A C, Machell J R, Wynne-Hughes G T, Hunt N P and Lewis M P 2008 Alpha v beta 3 and alpha v beta 5 integrins and their role in muscle precursor cell adhesion Biol. Cell 100 465-77
27. Singelyn J M et al 2012 Catheter-deliverable hydrogel derived from decellularized ventricular extracellular matrix increases endogenous cardiomyocytes and preserves cardiac function post-myocardial infarction J. Am. Coll. Cardiol. 59 751-63
28. Tan G, Shim W, Gu Y, Qian L, Chung Y Y, Lim S Y, Yong P, Sim E and Wong P 2010 Differential effect of myocardial matrix and integrins on cardiac differentiation of human mesenchymal stem cells Differentiation 79 260-71
29. Toma C, Pittenger M F, Cahill K S, Byrne B J and Kessler P D 2002 Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart Circulation 105 93-8
30. Uemura R, Xu M, Ahmad N and Ashraf M 2006 Bone marrow stem cells prevent left ventricular remodeling of ischemic heart through paracrine signaling Circulation Res. 98 1414-21
31. Uriel S, Labay E, Francis-Sedlak M, Moya M L, Weichselbaum R R, Ervin N, Cankova Z and Brey E M 2009 Extraction and assembly of tissue-derived gels for cell culture and tissue engineering Tissue Eng. Part C 15 309-21
32. Wang Y et al 2009 A new transmyocardial degradable stent combined with growth factor, heparin, and stem cells in acute myocardial infarction Cardiovasc. Res. 84 461-9
33. Whalen G F, Shing Y and Folkman J 1989 The fate of intravenously administered bFGF and the effect of heparin Growth Factors 1 157-64
34. Wollert K C et al 2004 Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial Lancet 364 141-8
35. Zhang G W, Liu X C, Li-Ling J, Luan Y, Ying Y N, Wu X S, Zhao C H, Liu T J and Lu F 2011 Mechanisms of the protective effects of BMSCs promoted by TMDR with heparinized bFGF-incorporated stent in pig model of acute myocardial ischemia J. Cell. Mol. Med. 15 1075-86